PHIO (Phio Pharmaceuticals) Days Payable: 0.00 (As of Mar. 2026)

What is Phio Pharmaceuticals Days Payable?

Phio Pharmaceuticals PHIO -0.97% 28 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates PHIO with a GF Score™ of 28/100. The stock has 1 warning sign investors should review. Among 701 Biotechnology companies, Phio Pharmaceuticals ranks worse than 142653.21% on this metric.

Phio Pharmaceuticals's average Accounts Payable for the three months ended in Mar. 2026 was $0.35 Mil. Phio Pharmaceuticals's Cost of Goods Sold for the three months ended in Mar. 2026 was $0.00 Mil.

The historical rank and industry rank for Phio Pharmaceuticals's Days Payable or its related term are showing as below:

PHIO's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 112.84
* Ranked among companies with meaningful Days Payable only.

Phio Pharmaceuticals's Days Payable stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00). stayed the same

Phio Pharmaceuticals Days Payable Related Terms

Phio Pharmaceuticals Days Payable Historical Data

* Premium members only.

The historical data trend for Phio Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phio Pharmaceuticals Days Payable Chart

Phio Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Days Payable

Get a 7-Day Free Trial

0.00

Phio Pharmaceuticals Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Days Payable	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

PHIO vs PBM, KPRX, OSRH: Days Payable Comparison

For the Biotechnology subindustry, Phio Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Phio Pharmaceuticals Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Phio Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Phio Pharmaceuticals's Days Payable falls into.

Save Embed

28GF Score

Phio Pharmaceuticals Corp PHIO

Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Phio Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Phio Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

	Days Payable (A: Dec. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2024 )	+	Accounts Payable (A: Dec. 2025 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2025 )	*	Days in Period
=	( (0.253	+	0.435)	/	2 )	/	0	*	365
=	0.344					/	0	*	365
=	N/A

Phio Pharmaceuticals's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

	Days Payable (Q: Mar. 2026 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2025 )	+	Accounts Payable (Q: Mar. 2026 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
=	( (0.435	+	0.26)	/	2 )	/	0	*	365 / 4
=	0.3475					/	0	*	365 / 4
=	N/A

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 0.00 mean?

Phio Pharmaceuticals (PHIO) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Phio Pharmaceuticals and its competitors. According to the industry distribution chart, Phio Pharmaceuticals ranks #999999 out of 701 companies in the Biotechnology industry.

Is Phio Pharmaceuticals' Days Payable too high?

Phio Pharmaceuticals' current Days Payable is 0.00. Based on the distribution chart, Phio Pharmaceuticals ranks #999999 out of 701 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Phio Pharmaceuticals has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.

How does Phio Pharmaceuticals' Days Payable compare to PBM and KPRX?

According to the Biotechnology industry distribution chart, Phio Pharmaceuticals ranks #999999 out of 701 companies for Days Payable. This places Phio Pharmaceuticals in the lower half of its industry. The industry median Days Payable is 112.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Biotechnology company?

The median Days Payable among Biotechnology companies is 112.84, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Phio Pharmaceuticals and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phio Pharmaceuticals's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Phio Pharmaceuticals stock overvalued right now?

Phio Pharmaceuticals (PHIO) has a current Days Payable of 0.00. The current Days Payable is 0.00. Phio Pharmaceuticals' overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For Phio Pharmaceuticals (PHIO), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Phio Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies PBM KPRX OSRH TOVX INTS CRIS ADAPY BCLI CALC ICU VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address 411 Swedeland Road, Suite 23-1080, King of Prussia, PA, USA, 19406

Website https://www.phiopharma.com

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.

28GF Score

Get the complete analysis for PHIO

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.02

Price

View PHIO Analysis

See Days Payable data for all stocks →